Practice Innovation Learning Lab (PILL-Rx)

Stay tuned for details on our next sessions of PILL-Rx in 2025! 

If you would like to submit any questions in advance of the session, please email [email protected]. You may also wish to browse our Past Session recordings below.

Were you interested in attending a PILL-Rx Session, but unable to attend live? You can view past event recordings via the links below. 

PILL-Rx Series Three (October 2024 - April 2025)

• Collaborative Practice Agreements in the Community Pharmacy (April 30, 2025)
   
• Implementation of MTM in Community Pharmacy (March 26, 2025)
   
• Travel Vaccines in Community Pharmacy (January 29, 2025)
   
• Free Narcan! Overview of Programming at Essentia Health (November 20, 2024)
   
• Immunization Check-in & Updates! (October 2, 2024). 

PILL-Rx Series Two (February - August 2024)

• RoundtableRx (August 21, 2024). Here is a link to the slides from this session. CE is available for watching this video. 
   
• Fertility Clinic Services (July 31, 2024). CE is available for watching this video.
   
• Self-administered Hormonal Contraceptive Prescribing (June 27, 2024). CE is available for watching this video. 
   
• Innovative Pharmacy Services: Meeting Public Health Needs through an Expedited Partner Therapy Community Pharmacy Program (May 22, 2024). CE is available for watching this video.
   
• Pharmacogenomics: a community pharmacy implementation program (April 24, 2024). CE is available for watching this video. 
   
• Expedited Partner Therapy (EPT): Review of Dispensing (March 20, 2024). CE is available for watching this video. 
   
• Pharmacist Prescribing and Dispensing: a Focus on Naloxone (Feb 28, 2024). Here is a link to the slides from this session. CE is available for watching this video. 

PILL-Rx Series One (June - November 2023)

• Inaugural PILL-Rx recorded session (June 28, 2023)
  • SWOT Analysis Worksheet
     
• PILL-Rx Session Two: Non-DIR Reimbursement Opportunities for Pharmacist Services (July 26, 2023)
  • Revenue Opportunities Worksheet
     
• PILL-Rx Session Three: Prioritizing MTM in Community Pharmacy Practice (August 22 & 23, 2023): Session not recorded; please email [email protected] if you are interested in more details regarding this seminar.
   
• PILL-Rx Session Four: Immunization Check-in (Sept 27, 2023)
   
• PILL-Rx Session Five: Innovation Conversation (Oct 12, 2023) was held as a live session at the MPhA Annual Meeting & MTM Symposium held in Plymouth, MN. This session was not recorded. 
   
• PILL-Rx Session Six: Using Medication Synchronization to Transform Workflow (Oct 25, 2023)
   
• PILL-Rx Session Seven: Establishment of a Test and Treat Program (Nov 28, 2023)

In support of improving patient care, continuing education requirements for PILL-Rx are planned and implemented by The National Center for Interprofessional Practice and Education Office of Interprofessional Continuing Professional Development (OICPD). The National Center OICPD is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team. Where applicable, each live session hosted as part of this series is approved for 1.0 contact hour for both Pharmacists and Pharmacy Technicians. Following successful completion of the post-session evaluation, participant data will be submitted to The NABP Monitor within 10 days. 

As a Jointly Accredited Provider of Interprofessional Continuing Education Credit, the National Center for Interprofessional Practice and Education Office of Interprofessional Continuing Professional Development (OICPD) complies with the ACCME and Joint Accreditors’ Standards for Integrity and Independence in Accredited Continuing Education. The National Center has a conflict of interest policy that requires all individuals involved in the development, planning, implementation, peer review and/or evaluation of an activity to disclose any financial relationships with ineligible companies. The National Center performs a thorough review of the content of the accredited activity to ensure that any financial relationships have no influence on the content of accredited activities. All potential conflicts of interest that arise based on these financial relationships are mitigated prior to the accredited activity.

This programming is supported by the UMN CoP Center for Leading Healthcare Change.